Latest Stories

• 

  COVID-19

  College Station Bio-Manufacturing Center To Produce COVID-19 Vaccines

  FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.

• 

  COVID-19

  COVID-19 Can Affect Pets

  Positive tests in a household necessitate extra protection for pets, Texas A&M experts say.

• 

  COVID-19

  Dental Professor Leads Texas Air National Guard Medics At COVID-19 Testing Sites

  Clinical assistant professor Karl Woodmansey oversees a team of medics at several El Paso testing sites.

• 

  COVID-19

  Texas A&M Readies To Welcome Students Back To Campus

  Provost Fierke: ‘Taking all possible measures to restore on-campus and in-person research and teaching.’

• 

  COVID-19

  For Florida, The Coronavirus Pandemic Was A Perfect Storm

  Texas A&M health public health researchers say Florida's COVID-19 response stands out for both its absence of statewide policies and the unique challenges the state faces.

• 

  COVID-19

  TEES Researchers Developing COVID-19 Spike Proteins To Identify Antibodies

  Preventing the virus from binding to cells could prevent future infections.

• 

  COVID-19

  With COVID-19 Cases Surging In Texas, What’s Next?

  Positive cases, hospitalizations and deaths are on the rise. Texas A&M infectious disease experts discuss the direction of the pandemic.

• 

  COVID-19

  New Book By Texas A&M Faculty Helps Children Understand COVID-19

  The book from College of Education & Human Development faculty members aims to help kids understand the pandemic while easing their fears.

• 

  COVID-19

  New COVID Investigation Operations Center To Help Texas A&M Safely Resume In-Person Classes

  The unique interagency agreement between Texas A&M and the Brazos County Health District aims to contain COVID-19 transmission on campus.

• 

  COVID-19

  Texas A&M, MD Anderson Scientists Testing Inhaled Therapeutic To Protect Against COVID-19

  The Food and Drug Administration has approved two human clinical trials for the drug.